Literature DB >> 19740990

Adult AIDS-like disease in a novel inducible human immunodeficiency virus type 1 Nef transgenic mouse model: CD4+ T-cell activation is Nef dependent and can occur in the absence of lymphophenia.

Mir Munir Ahmed Rahim1, Pavel Chrobak, Chunyan Hu, Zaher Hanna, Paul Jolicoeur.   

Abstract

CD4C/HIV(nef) transgenic (Tg) mice express Nef in CD4+ T cells and in the cells of the macrophage/monocyte/dendritic lineage, and they develop an AIDS-like disease similar to human AIDS. In these mice, Nef is constitutively expressed throughout life. To rule out the contribution of any developmental defects caused by early expression of Nef, we generated inducible human immunodeficiency virus type 1 (HIV-1) Nef Tg mice by using the tetracycline-inducible system. Faithful expression of the Nef transgene was induced in (CD4C/rtTA x TRE/HIV(Nef)) or (CD4C/rtTA2S-M2 x TRE/HIV(Nef)) double-Tg mice upon doxycycline (DOX) treatment in drinking water. Long-term treatment of these mice with DOX also led to loss, apoptosis, and activation of CD4+ T cells, this latter phenotype being observed even with low levels of Nef. These phenotypes could be transferred by bone marrow (BM) transplantation, indicating a hematopoietic cell autonomous effect. In addition, in mixed Tg:non-Tg BM chimeras, only Tg and not non-Tg CD4+ T cells exhibited an effector/memory phenotype in the absence of lymphopenia. Finally, the DOX-induced double-Tg mice developed nonlymphoid organ diseases similar to those of CD4C/HIV(Nef) Tg mice and of humans infected with HIV-1. These results show for the first time that adult mice are susceptible to the detrimental action of Nef and that Nef-mediated T-cell activation can be independent of lymphopenia. These Tg mice represent a unique model which is likely to be instrumental for understanding the cellular and molecular pathways of Nef action as well as the main characteristics of immune reconstitution following DOX withdrawal.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19740990      PMCID: PMC2772706          DOI: 10.1128/JVI.01466-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  A new entry route for HIV.

Authors:  B R Cullen
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

2.  Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators.

Authors:  A Simmons; V Aluvihare; A McMichael
Journal:  Immunity       Date:  2001-06       Impact factor: 31.745

3.  Nef modulation of HIV type 1 gene expression and cytopathicity in tissues of HIV transgenic mice.

Authors:  P Dickie
Journal:  AIDS Res Hum Retroviruses       Date:  2000-05-20       Impact factor: 2.205

4.  Expression of simian immunodeficiency virus nef in immune cells of transgenic mice leads to a severe AIDS-like disease.

Authors:  Marie-Chantal Simard; Pavel Chrobak; Denis G Kay; Zaher Hanna; Serge Jothy; Paul Jolicoeur
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Evidence of productively infected CD8+ T cells in patients with AIDS: implications for HIV-1 pathogenesis.

Authors:  K Saha; J Zhang; B Zerhouni
Journal:  J Acquir Immune Defic Syndr       Date:  2001-03-01       Impact factor: 3.731

6.  Distinct regulatory elements are required for faithful expression of human CD4 in T cells, macrophages, and dendritic cells of transgenic mice.

Authors:  Z Hanna; N Rebai; J Poudrier; P Jolicoeur
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

7.  Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia.

Authors:  Guido Silvestri; Donald L Sodora; Richard A Koup; Mirko Paiardini; Shawn P O'Neil; Harold M McClure; Silvija I Staprans; Mark B Feinberg
Journal:  Immunity       Date:  2003-03       Impact factor: 31.745

8.  Selective expression of human immunodeficiency virus Nef in specific immune cell populations of transgenic mice is associated with distinct AIDS-like phenotypes.

Authors:  Zaher Hanna; Elena Priceputu; Pavel Chrobak; Chunyan Hu; Véronique Dugas; Mathieu Goupil; Miriam Marquis; Louis de Repentigny; Paul Jolicoeur
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

9.  Persistent immune activation in HIV-1 infection is associated with progression to AIDS.

Authors:  Mette D Hazenberg; Sigrid A Otto; Birgit H B van Benthem; Marijke Th L Roos; Roel A Coutinho; Joep M A Lange; Dörte Hamann; Maria Prins; Frank Miedema
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

Review 10.  Human intrathymic development: a selective approach.

Authors:  J Plum; M De Smedt; G Leclercq; T Taghon; T Kerre; B Vandekerckhove
Journal:  Semin Immunopathol       Date:  2008-10-17       Impact factor: 9.623

View more
  15 in total

1.  Advances in our understanding of the pathogenesis of HIV-1 associated nephropathy in children.

Authors:  Patricio E Ray; Chien-An A Hu
Journal:  Future Virol       Date:  2011-07       Impact factor: 1.831

2.  Heterologous Src homology 4 domains support membrane anchoring and biological activity of HIV-1 Nef.

Authors:  Miriam M Geist; Xiaoyu Pan; Silke Bender; Ralf Bartenschlager; Walter Nickel; Oliver T Fackler
Journal:  J Biol Chem       Date:  2014-04-04       Impact factor: 5.157

3.  Physiologic changes in a nonhuman primate model of HIV-associated pulmonary arterial hypertension.

Authors:  M Patricia George; Hunter C Champion; Marc Simon; Siobhan Guyach; Rebecca Tarantelli; Heather M Kling; Alexandra Brower; Christopher Janssen; Jessica Murphy; Jonathan P Carney; Alison Morris; Mark T Gladwin; Karen A Norris
Journal:  Am J Respir Cell Mol Biol       Date:  2012-12-13       Impact factor: 6.914

4.  HIV-1 Nef and Vpu are functionally redundant broad-spectrum modulators of cell surface receptors, including tetraspanins.

Authors:  Claudia Haller; Birthe Müller; Joëlle V Fritz; Miguel Lamas-Murua; Bettina Stolp; François M Pujol; Oliver T Keppler; Oliver T Fackler
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

5.  Human immunodeficiency virus transgenic rats exhibit pulmonary hypertension.

Authors:  Amie K Lund; Joann Lucero; Lindsay Herbert; Yushi Liu; Jay S Naik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-06-17       Impact factor: 5.464

6.  Pulmonary vascular lesions are common in SIV- and SHIV-env-infected macaques.

Authors:  M Patricia George; Alexandra Brower; Heather Kling; Tim Shipley; Jan Kristoff; Todd A Reinhart; Michael Murphey-Corb; Mark T Gladwin; Hunter C Champion; Alison Morris; Karen A Norris
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-21       Impact factor: 2.205

Review 7.  Mechanisms of HIV-1 Nef function and intracellular signaling.

Authors:  John L Foster; Sarah J Denial; Brenda R S Temple; J Victor Garcia
Journal:  J Neuroimmune Pharmacol       Date:  2011-02-19       Impact factor: 4.147

Review 8.  APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy.

Authors:  Jeffrey B Kopp; Jurgen Heymann; Cheryl A Winkler
Journal:  Semin Nephrol       Date:  2017-11       Impact factor: 5.299

9.  HIV-associated nephropathy: a diagnosis in evolution.

Authors:  Patricio E Ray
Journal:  Nephrol Dial Transplant       Date:  2012-05-13       Impact factor: 5.992

10.  μ-Lat: A mouse model to evaluate human immunodeficiency virus eradication strategies.

Authors:  Hannah S Sperber; Padma Priya Togarrati; Kyle A Raymond; Mohamed S Bouzidi; Renata Gilfanova; Alan G Gutierrez; Marcus O Muench; Satish K Pillai
Journal:  FASEB J       Date:  2020-09-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.